Opposing Gene Patenting

A draft bill introduced in May 2019 sought to reform Section 101 of the U.S. Patent Act. If passed, the legislation would allow for the patenting of genes by effectively overturning the 2013 Association for Molecular Pathology (AMP) vs. Myriad Supreme Court decision.



ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy